Discover
CLOV
Clover Health Investments, Corp.
4.78
52 x 4.77
46 x 4.78
bid
ask
-
0.01
0.31%
12:01 PM
timesize
| Ytd | 103.19% | |
| 1y | 48.29% |
4.69
day range
4.81
1.58
52 week range
5.59
| Open | 4.75 | Prev Close | 4.79 | Low | 4.69 | High | 4.81 | Mkt Cap | 2.48B |
| Vol | 809.22K | Avg Vol | 7.68M | EPS | -0.12 | P/E | -39.92 | Forward P/E | 81.97 |
| Beta | 2.41 | Short Ratio | 2.44 | Inst. Own | 29.98% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-05 | 50-d Avg | 4.36 | 200-d Avg | 2.91 | 1yr Est | 4.15 |
Earning
| Date | For | Estimate | Reported | Surprise | surprise % |
|---|---|---|---|---|---|
| 2026-08-05 | 2026-06 | 0.05 | N/A | N/A | N/A |
| 2026-05-06 | 2026-03 | 0.07 | 0.07 | N/A | N/A |
| 2026-02-26 | 2025-12 | -0.1 | -0.05 | 0.05 | 51.04% |
| 2025-11-04 | 2025-09 | 0.02 | -0.05 | -0.07 | -350.00% |
| 2025-08-05 | 2025-06 | 0.03 | 0.03 | N/A | N/A |
| 2025-05-06 | 2025-03 | -0.07 | 0.05 | 0.12 | 171.43% |
Upgrade / Downgrade
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| 2026-06-11 | UBS | Upgrade | Neutral | Neutral |
| 2026-06-04 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-20 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2026-03-05 | Leerink Partners | Upgrade | Market Perform | Market Perform |
| 2026-01-20 | Canaccord Genuity | Upgrade | Buy | Buy |
| 2025-11-06 | Canaccord Genuity | Upgrade | Buy | Buy |
Profile
Clover Health Investments, Corp. provides medicare advantage plans in the United States. The company offers preferred provider organization and health maintenance organization plans to medicare-eligible individuals. It also operates Clover Assistant, a software platform for physicians to detect, identify, and manage chronic diseases. The company was founded in 2014 and is based in Wilmington, Delaware.
Insider Holder
| Date | Name | Relation | Quantity | Description |
|---|---|---|---|---|
| 2025-01-05 | CLINTON CHELSEA | Director | 602.81K | Stock Award(Grant) |
| 2026-01-06 | GARIPALLI VIVEK | Director and Beneficial Owner of more than 10% of a Class of Security | 1.86M | Conversion of Exercise of derivative security |
| 2026-01-05 | KOUZOUKAS DEMETRIOS L | Director | 605.98K | Stock Award(Grant) |
| 2025-05-18 | KUIPERS PETER J | Chief Financial Officer | 6.35M | Stock Award(Grant) |
| 2026-05-12 | PRIEST BRADY PATRICK | Officer | 2.04M | Sale |
| 2026-07-07 | REYNOSO JAMIE L. | Officer | 2.83M | Sale |
Institution Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-03-30 | BlackRock Inc | 31.84M | 0.00 | 6.05% |
| 2025-12-30 | Vanguard Group Inc | 23.49M | 0.00 | 4.46% |
| 2026-03-30 | Vanguard Capital Management, LLC | 16.98M | 0.00 | 3.22% |
| 2026-03-30 | Geode Capital Management, LLC | 10.06M | 0.00 | 1.91% |
| 2026-03-30 | State Street Corp | 9.56M | 0.00 | 1.82% |
| 2026-03-30 | Charles Schwab Investment Management Inc | 5.30M | 0.00 | 1.01% |
Fund Ownership
| Report Date | Organization | Position | Value | Percentage |
|---|---|---|---|---|
| 2026-04-29 | Vanguard Total Stock Mkt Idx Inv | 12.62M | 0.00 | 2.40% |
| 2026-05-28 | iShares Russell 2000 ETF | 9.71M | 0.00 | 1.84% |
| 2026-04-29 | Vanguard Institutional Extnd Mkt Idx Tr | 4.49M | 0.00 | 0.85% |
| 2026-03-30 | Fidelity Small Cap Index | 4.01M | 0.00 | 0.76% |
| 2026-05-28 | iShares Russell 2000 Growth ETF | 3.32M | 0.00 | 0.63% |
| 2025-12-30 | Russell 2000 Equity Index Fund B | 2.56M | 0.00 | 0.49% |
Dividend
| Dividend | Date |
|---|---|
| 0.1 | 2021-08-23 |